BioSpace News Archive

BridgeBio Pharma, Inc. today announced three new academic collaborations with MUSC Foundation for Research Development, Stanford University and the University of Pittsburgh (Pitt) to translate cutting-edge discoveries into potential therapies for patients with genetic diseases and genetically driven cancers.

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2021 on Thursday, July 29, 2021, before the U.S. financial markets open.

9 Meters Biopharma, Inc. today announced that John Temperato, CEO of 9 Meters Biopharma will participate in a virtual fireside chat at the William Blair Biotech Focus Conference being held July 14-15, 2021 and invites investors to join live via webcast.

Amolyt Pharma today announced that the company has made two appointments to its Board of Directors following its Annual General Meeting, which was held on June 30, 2021.

BeyondSpring Inc. today announced that management will participate in the William Blair Biotech Focus Conference being held virtually on July 14-15, 2021 and be available for 1x1 meetings.

The demand within the global surgical tourniquets market is growing on account of advancements in invasive diagnostics and treatment.

Since the past decade, a large number of surgical procedures are moving out of the traditional ways, and they are replaced by minimally invasive techniques which is driving the market of smoke evacuation system globally.

The global microRNA market is predicted to expand at a whopping growth rate over the 2020 – 2030 forecast period.

Contrast medium or diagnostic imaging agent is a substance that enhances the contrast of structures and fluids present inside the body in medical imaging.

NovaBay® Pharmaceuticals, Inc., a pharmaceutical company focusing on commercializing Avenova® for the eye care market and CelleRx® for the beauty market, announces that management will participate at the upcoming investment conferences: